SALT LAKE CITY, Oct. 01, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (LFVN) (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at ...
SALT LAKE CITY, March 16, 2026 (GLOBE NEWSWIRE)-- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the ...
Expands intellectual property portfolio and underscores commitment to science-backed health and wellness solutionsSALT LAKE ...
SALT LAKE CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular ...
Strategic acquisition strengthens leadership position in direct sales and gut and microbiome health market SALT LAKE CITY, Oct. 02, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a ...
Breakthrough study paves the way for innovative, science-driven weight management solutions designed to activate optimal health at the cellular level* SALT LAKE CITY, Sept. 26, 2024 (GLOBE NEWSWIRE) - ...
LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today ...
LifeVantage Corporation (NASDAQ:LFVN) Q2 2026 Earnings Call Transcript February 4, 2026 LifeVantage Corporation misses on earnings expectations. Reported EPS is $0.05257 EPS, expectations were $0.22.
LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release ...
LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, successfully concluded its three-day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results